CyrusOne and Kansai Electric Power Company, Inc. (KEPCO) Announce Joint Venture
Innovative partnership to drive scalability and smart development in Japan DALLAS--(BUSINESS WIRE)--CyrusOne, a leading global…
3 years ago
Wire Stories
Ready, Set, Order: DoorDash and Australian Eateries Join Forces to Bring You $1 Weekend Deals* You Can’t Afford to Miss
MELBOURNE, Australia--(BUSINESS WIRE)--DoorDash has joined forces with some of Australia’s favourite local restaurants, offering up…
3 years ago
Thousand Oaks Biologics and GeneQuantum Healthcare Signed A Strategic Partnership Agreement for ADC Drug Development
SUZHOU, China--(BUSINESS WIRE)--Thousand Oaks Biologics Inc. (TOBio) and GeneQuantum Healthcare (Suzhou) Co., Ltd. (GQ) are…
3 years ago
TuxCare Announces Strategic Partnership with Cybertrust Japan to Support Country’s AlmaLinux Users
Companies collaborate to efficiently offer world-class support for Japan’s vast prospective user base Uniquely arms…
3 years ago
AlmaLinux OS Foundation Welcomes Cybertrust Japan as a Platinum Sponsor
Collaboration aims to bring further stability and security to the RHEL clone FORT MYERS, Fla.--(BUSINESS…
3 years ago
Mitsubishi Electric and Movensys form Alliance to Expand AC Servo and Motion Control Businesses
TOKYO--(BUSINESS WIRE)--Mitsubishi Electric Corporation (Headquarters: Chiyoda-ku, Tokyo, President and CEO: Kei Uruma, "Mitsubishi Electric") and…
3 years ago
DNP: Newly Designed LCD Backlight System Components Achieve Both High Luminance and Wide Viewing Angle
- Works to reduce parts numbers, achieves thinness and contributes to CO2 emission reduction -…
3 years ago
Oasis Announces “Hokuetsu Corp Gov†Campaign (Stock Code: 3865 JT)
* Oasis calls for Hokuetsu shareholders to vote against CEO Mr. Kishimoto at upcoming AGM…
3 years ago
The Quad Investors Network Launches with Advisory Board, Expert Groups
ARLINGTON, Va.--(BUSINESS WIRE)--The Quad Investors Network formally launched today in parallel with the Quad Leaders…
3 years ago
Alpine Immune Sciences to Present Data from RUBY-1, a Phase 1 Study of Povetacicept, at Upcoming Scientific Congresses
SEATTLE--(BUSINESS WIRE)--Alpine Immune Sciences, Inc. (NASDAQ: ALPN), a leading clinical-stage immunotherapy company focused on developing…
3 years ago